Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Feedback Inhibition

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!

Molecules and Compounds

Molecules and Compounds

Atoms and Molecules

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Types of Signaling Molecules

Types of Signaling Molecules

In multicellular organisms, many molecules transmit signals between cells to pass information. These signals vary in complexity and include small peptides, nucleotides, steroids, fatty acid derivatives, and dissolved gases such as nitric oxide. Some signaling molecules diffuse through the plasma membrane to act locally between neighboring cells or travel long distances. Others remain attached to the cell surface, transmitting information to other cells only when they make contact. In some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models.

Brain : a journal of neurology·2025

Same author

The design, synthesis, and biological evaluation of 5,6,7,8-tetrahydropteridines as anti-inflammatory compounds.

Organic & biomolecular chemistry·2024

Same author

Insights into the structure of NLR family member X1: Paving the way for innovative drug discovery.

Computational and structural biotechnology journal·2024

Same author

Author Correction: Caspase-1-dependent inflammasomes mediate photoreceptor cell death in photo-oxidative damage-induced retinal degeneration.

Scientific reports·2024

Same author

o-Vanillin binds covalently to MAL/TIRAP Lys-210 but independently inhibits TLR2.

Journal of enzyme inhibition and medicinal chemistry·2024

Same author

Characterization and inhibition of inflammasome responses in severe and non-severe asthma.

Respiratory research·2023

Search research articles

Related Experiment Video

Updated: Feb 1, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

Inhibiting Inflammasomes with Small Molecules.

Avril A B Robertson¹

¹School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia. a.robertson3@uq.edu.au.

Experientia Supplementum (2012)

|December 12, 2018

Summary

Small molecules targeting the NLRP3 inflammasome show therapeutic promise. Research details synthetic, known, and natural compounds, highlighting strategies and challenges in developing NLRP3 inflammasome inhibitors for disease treatment.

Keywords:

Anti-inflammatory Drug discovery Immunomodulation Inflammasome NLRP3

More Related Videos

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

Related Experiment Videos

Last Updated: Feb 1, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

Area of Science:

Immunology
Medicinal Chemistry
Drug Discovery

Background:

Inflammasomes, particularly NLRP3, are key regulators of inflammation with significant therapeutic potential.
Targeting inflammasomes is a rapidly advancing field, evidenced by increasing patent filings for novel compound classes.

Purpose of the Study:

To review and detail small-molecule inhibitors of the NLRP3 inflammasome.
To provide an overview of diverse chemical structures and strategies employed in NLRP3 inflammasome modulation.

Main Methods:

Literature review of published synthetic molecules, known drugs, and natural products targeting NLRP3.
Analysis of characterization data including cell-based screening and pharmacokinetic profiling where available.

Main Results:

A range of small-molecule NLRP3 inflammasome inhibitors, including synthetic compounds, existing drugs, and natural products, are discussed.
Many inhibitors have undergone extensive characterization, including in vivo proof-of-concept studies.
Challenges such as lack of rigorous studies and off-target effects are noted for several compounds.

Conclusions:

Small-molecule modulation of the NLRP3 inflammasome represents a promising therapeutic avenue.
Diverse chemical scaffolds and strategies are being explored, but further rigorous studies are needed to overcome challenges and fully realize therapeutic benefits.